Recruiting PHASE2 INTERVENTIONAL 2-arm NCT03514589

NeSST2: The Development of a Noninvasive Short Synacthen Test (NeSST2)

NeSST2: A Multi-stage Clinical Study to Develop a Non-invasive Short Synacthen Test (SST)

Sponsor: Sheffield Children's NHS Foundation Trust

Interventions IV tetracosactide nasal Tetracosactide

Updated 8 times since 2018 Last updated: Dec 2, 2024 Started: Oct 12, 2012 Primary completion: Dec 1, 2025 Completion: Dec 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03514589, this PHASE2 trial focuses on Adrenal Suppression and remains actively recruiting participants. Sponsored by Sheffield Children's NHS Foundation Trust, it has been updated 8 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Jan 2025 — Present [monthly]

Recruiting PHASE2
Sep 2024 — Jan 2025 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Oct 2023 — Jul 2024 [monthly]

Recruiting PHASE2

Status: Suspended → Recruiting
Sep 2022 — Oct 2023 [monthly]

Suspended PHASE2

▶ Show 3 earlier versions

Jan 2021 — Sep 2022 [monthly]

Suspended PHASE2
Feb 2020 — Jan 2021 [monthly]

Suspended PHASE2
Jun 2018 — Feb 2020 [monthly]

Suspended PHASE2

First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sheffield Children's NHS Foundation Trust

Data source: Sheffield Children's NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sheffield, United Kingdom